ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

ACCC Applauds Launch of New Billing Code for Genetic Counselors

September 24, 2024

Author(s):

Rachel Radwan

ACCC Applauds Launch of New Billing Code for Genetic Counselors

As a result of efforts by the National Society of Genetic Counselors (NSGC) and the American College of Medical Genetics and Genomics (ACMG), a new CPT® code for genetic counselors will launch in January 2025. Under code 96041, billing will be based on the total time the genetic counselor spends with the patient on the date of the encounter.

An Important Step Forward

This new code represents an important shift in the landscape of genetic counseling. The existing CPT code 96040, which has been in use since it was first proposed in 2005, allowed reporting for 30-minute face-to-face genetic counseling sessions to be billed as a stackable 30-minute unit charge. However, code 96041 better reflects the work genetic counselors do and does not have any time constraints. “The new 96041 code allows genetic counselors to be recognized for all the work they do for a patient on the day of the appointment outside of the physical appointment, and puts them in a better position to bill appropriately for their services,” commented Lindsey Byrne, MS, CGC, certified genetic counselor and clinical assistant professor of Internal Medicine at The Ohio State University Comprehensive Cancer Center.

Still, genetic counselors are not recognized nationally by the Centers for Medicare & Medicaid Services (CMS) as health care providers, greatly inhibiting reimbursement opportunities. Some genetic counselors may bill a facility fee if they run a clinic independently, but smaller facilities often find it difficult to pay for a provider who cannot be directly reimbursed for their services, thus limiting the hiring of genetic counselors.

In order to provide patients with the genetic counseling services they need, many medical organizations and associations, including ACCC, have been advocating for the Access to Genetic Counselor Services Act for years. Among other components, this act would give genetic counselors provider status under Medicare Part B, thus allowing direct reimbursement to genetic counselors for services furnished under Medicare Part B. 

“The new genetic counseling CPT code is a big step in the right direction toward increasing patient access to genetic counseling,” said ACCC Board of Trustees Member Leigha Senter-Jamieson, MS, CGC, a licensed genetic counselor and clinical professor of Internal Medicine at The Ohio State University Comprehensive Cancer Center. “A great deal of work went into ensuring that the code accurately captures the specialized patient services that genetic counselors provide. Now, we just need the passage of the Access to Genetic Counselor Services Act to finally recognize genetic counselors as providers of this valuable service.”

An Unmet Need

With 5% to 10% of cancers being hereditary, the need for accessible genetic counseling services is greater than ever. Early identification of individuals with a hereditary cancer predisposition can improve surveillance and prevention efforts to save lives. From prevention and screening to treatment and survivorship, genetic counseling has been demonstrated to significantly improve patient outcomes and patient satisfaction. Refer to ACCC’s Cancer Diagnostics education program page for more information and a portfolio of comprehensive resources. 

Unfortunately, over half of patients eligible for genetic counseling are not referred to the appropriate services or do not have it offered to them. In some cases, this oversight is due to a lack of physician knowledge about ordering and interpreting genetic tests, as the results can be complex. Having a genetic counselor as part of the care team ensures that patients who stand to benefit from genetic testing are referred to the appropriate services, and that there is a health care provider uniquely trained to support patients through the complex process.

In the coming weeks, NSGC will provide more information and resources regarding the new CPT code and engage with members and external partners accordingly. The approval of code 96041 is an important milestone in ensuring genetic counselors are recognized for the vital work and services they provide for patients and reflects the longstanding dedication of NSGC and ACMG.

A special thank you to Lindsey Byrne and Leigha Senter-Jamieson for their contributions to this post.

Related Content

Making AI Practical in Oncology: Lessons from Highlands OncologyACCCBuzz Blog

Making AI Practical in Oncology: Lessons from Highlands Oncology

May 6, 2026

Small Cell SMASHERS: How Community, Advocacy, and Emerging Science Are Changing the Narrative in Small Cell Lung CancerACCCBuzz Blog

Small Cell SMASHERS: How Community, Advocacy, and Emerging Science Are Changing the Narrative in Small Cell Lung Cancer

April 24, 2026

Partnering to Deliver Targeted Treatment: Fox Chase Cancer Center and OmniscopeACCCBuzz Blog

Partnering to Deliver Targeted Treatment: Fox Chase Cancer Center and Omniscope

Rachel Radwan

April 22, 2026

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership SummitACCCBuzz Blog

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership Summit

Gabrielle Stearns

April 20, 2026

Bispecific Antibodies Are Moving Forward; So Are the Implementation QuestionsACCCBuzz Blog

Bispecific Antibodies Are Moving Forward; So Are the Implementation Questions

Rifeta Kajdić Hodžić

April 17, 2026

Highlights From Volume 41, Number 2 Oncology IssuesACCCBuzz Blog

Highlights From Volume 41, Number 2 Oncology Issues

Gabrielle Stearns

April 15, 2026

Developing Clinical Insight, Professional Competencies, and Strategic Awareness: NCCN 2026 Annual ConferenceACCCBuzz Blog

Developing Clinical Insight, Professional Competencies, and Strategic Awareness: NCCN 2026 Annual Conference

Rachel Radwan; Gabrielle Stearns

April 8, 2026

Representing Veterans in Clinical Trials Through Public-Private Partnerships: A Q&A With NAVREFACCCBuzz Blog

Representing Veterans in Clinical Trials Through Public-Private Partnerships: A Q&A With NAVREF

Gabrielle Stearns

March 26, 2026

Upcoming Events

ACCC 43rd National Oncology Conference
Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston
Register Now!
WSOS 2026 Laramie Meeting
Oncology

WSOS 2026 Laramie Meeting

In Person Conference & ConventionMay 20, 2026 at 5:30 PM MDT222 South 22nd Street, Laramie, WY, USAUniversity of Wyoming – Rochelle Gateway Center, Laramie
Register Now!
WAHO 2026 Welcome Reception
Oncology

WAHO 2026 Welcome Reception

In Person Conference & ConventionMay 30, 2026 at 6:00 PM CDT1060 W Addison St, Chicago, IL, USAWrigley Field , Chicago
Register Now!
IOS 2026 Welcome Reception
Oncology

IOS 2026 Welcome Reception

In Person Conference & ConventionMay 30, 2026 at 6:00 PM CDT1060 West Addison Street, Chicago, IL, USAWrigley Field, Chicago
Register Now!
WSOS 2026 Rock Springs Meeting
Oncology

WSOS 2026 Rock Springs Meeting

In Person Conference & ConventionJune 9, 2026 at 5:30 PM MDT1675 Sunset Dr, Rock Springs, WY, USAHoliday Inn Rock Springs, Rock Springs
Register Now!
HSCO 2026 June Dinner Symposium
Oncology

HSCO 2026 June Dinner Symposium

In Person Conference & ConventionJune 10, 2026 at 5:30 PM HST3660 Waialae Ave, Honolulu, HI, USA3660 On The Rise, Honolulu
Register Now!
COS 2026 Dinner at the Denver Best of ASCO
Oncology

COS 2026 Dinner at the Denver Best of ASCO

In Person Meeting & NetworkingJune 26, 2026 at 5:30 PM MDT7000 Church Ranch Blvd, Westminster, CO, USADenver Marriott Westminster, Westminster
Register Now!
KaSCO 2026 Fellows Dinner
Oncology

KaSCO 2026 Fellows Dinner

In Person Conference & ConventionJuly 16, 2026 at 6:00 PM CDT101 West 22nd Street, Kansas City, MO, USALidia's Kansas City, Kansas City
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Making AI Practical in Oncology: Lessons from Highlands Oncology

Making AI Practical in Oncology: Lessons from Highlands Oncology

A recent discussion between ACCC and Highlands Oncology centered on how artificial intelligence can be implemented thoughtfully in cancer care to support clinicians and operations without compromising clinical judgement or patient care.

Small Cell SMASHERS: How Community, Advocacy, and Emerging Science Are Changing the Narrative in Small Cell Lung Cancer

Small Cell SMASHERS: How Community, Advocacy, and Emerging Science Are Changing the Narrative in Small Cell Lung Cancer

Small Cell SMASHERS was founded in 2023 as a patient-centered advocacy and education community designed to challenge long-standing narratives about small cell lung cancer and restore a sense of voice, connection, and hope for patients and their loved ones.

Partnering to Deliver Targeted Treatment: Fox Chase Cancer Center and Omniscope

Partnering to Deliver Targeted Treatment: Fox Chase Cancer Center and Omniscope

ACCCBuzz spoke with Fox Chase Cancer Center to learn more about its partnership with Omniscope, a leader in advanced molecular profiling technology, in hopes of developing an assay that accurately predicts which patients will respond well to immunotherapy based on the presence of certain T-cell clones.

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership Summit

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership Summit

On Friday, April 17, ACCC welcomed oncology leaders from around the country to Washington, DC for the inaugural ACCC Leadership Summit, a forum designed for executive-level decision-makers to engage in strategic dialogue, peer-to-peer exchange, and actionable insights at the highest level of oncology leadership.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Designing Care That Creates Value for Patients and the Health System - [Mini Podcast] Ep. 233

A Collaborative Approach to Health Policy Changes - [Mini Podcast] Ep. 232

Closing the Gap Between Innovation and Implementation: Strategic Partnerships in Oncology – [Mini Podcast] Ep. 231

Becoming a Smart Consumer of AI as an Oncology Leader – [Mini Podcast] Ep. 230

View All Podcasts

Latest from Oncology Issues

April 2026
April 2026
February 2026
December 2025
October 2025
August 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login